SW treatment (50 mg/kg, i.p.)reduced serum triglyceride, cholesterol, and low-density lipoprotein (LDL) levels in diabetic animals and significantly increased the insulin sensitivity index, thereby improving the dyslipidemic condition developed as a result of insulin resistance [65]. The gene discussed is INS; the disease is Insulin resistance.